Media

This project aims to implement Design Thinking in drug discovery to create a more effective approach for pharmaceutical trials and research. By emphasizing empathy and iterative testing, it enhances treatment personalization and effectiveness. Integrating Artificial Intelligence (AI) will refine Design Thinking models for healthcare and analyze AI decision-making in drug development. The project will utilize qualitative methods to gather insights and quantitative techniques like QSAR modeling to optimize drug candidates’ efficacy and safety. Ultimately, it seeks to improve clinical trial efficiency, strengthen stakeholder communication, and reduce costs in the drug discovery process.